Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) represent an important global threat. The aim of this study is to describe the clinical course and outcomes of patients with CRE infections treated with ceftazidime-avibactam (CAZ-AVI) compared to patients treated with other agents. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alraddadi, Basem M., Saeedi, Mohammed, Qutub, Mohammed, Alshukairi, Abeer, Hassanien, Ashraf, Wali, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724371/
https://www.ncbi.nlm.nih.gov/pubmed/31484510
http://dx.doi.org/10.1186/s12879-019-4409-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724371/
https://www.ncbi.nlm.nih.gov/pubmed/31484510
http://dx.doi.org/10.1186/s12879-019-4409-1

Ejemplares similares